Literature DB >> 7636974

Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins.

A Wistuba1, S Weger, A Kern, J A Kleinschmidt.   

Abstract

The proteins encoded by the adeno-associated virus type 2 (AAV-2) rep and cap genes obtained during a productive infection of HeLa cells with AAV-2 and adenovirus type 2 were fractionated according to solubility, cellular localization, and sedimentation properties. The majority of Rep and Cap proteins accumulated in the nucleus, where they distributed into a soluble and an insoluble fraction. Analysis of the soluble nuclear fraction of capsid proteins by sucrose density gradients showed that they formed at least three steady-state pools: a monomer pool sedimenting at about 6S, a pool of oligomeric intermediates sedimenting between 10 and 15S, and a broad pool of assembly products with a peak between 60 and 110S, the known sedimentation positions of empty and full capsids. While the soluble nuclear monomer and oligomer pool contained predominantly only two capsid proteins, the 30 to 180S assembly products contained VP1, VP2, and VP3 in a stoichiometry similar to that of purified virions. They probably represent different intermediates in capsid assembly, DNA encapsidation, and capsid maturation. In contrast, the cytoplasmic fraction of capsid proteins showed a pattern of oligomers continuously increasing in size without a defined peak, suggesting that assembly of 60S particles occurs in the nucleus. Soluble nuclear Rep proteins were distributed over the whole sedimentation range, probably as a result of association with AAV DNA. Subfractions of the Rep proteins with defined sedimentation values were obtained in the soluble nuclear and cytoplasmic fractions. We were able to coimmunoprecipitate capsid proteins sedimenting between 60 and 110S with antibodies against Rep proteins, suggesting that they exist in common complexes possibly involved in AAV DNA packaging. Antibodies against the capsid proteins, however, precipitated Rep78 and Rep68 predominantly with a peak around 30S representing a second complex containing Rep and Cap proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636974      PMCID: PMC189369     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.

Authors:  R W ATCHISON; B C CASTO; W M HAMMON
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

2.  Assembly of adeno-associated virus.

Authors:  M W Myers; B J Carter
Journal:  Virology       Date:  1980-04-15       Impact factor: 3.616

3.  Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation.

Authors:  R L Garcea; K Ballmer-Hofer; T L Benjamin
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Structural proteins of adenovirus-associated viruses.

Authors:  J A Rose; J V Maizel; J K Inman; A J Shatkin
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

5.  Nucleotide sequence and organization of the adeno-associated virus 2 genome.

Authors:  A Srivastava; E W Lusby; K I Berns
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

6.  Host range transforming gene of polyoma virus plays a role in virus assembly.

Authors:  R L Garcea; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

7.  Characterization of adenovirus-associated virus-induced polypeptides in KB cells.

Authors:  R M Buller; J A Rose
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

8.  Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants.

Authors:  P L Hermonat; M A Labow; R Wright; K I Berns; N Muzyczka
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

9.  Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function.

Authors:  J D Tratschin; I L Miller; B J Carter
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

10.  Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication.

Authors:  R M Buller; J E Janik; E D Sebring; J A Rose
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

View more
  59 in total

1.  Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure.

Authors:  M Moskalenko; L Chen; M van Roey; B A Donahue; R O Snyder; J G McArthur; S D Patel
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses.

Authors:  Jianming Qiu; Ramnath Nayak; Gregory E Tullis; David J Pintel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20.

Authors:  Dustin M McCraw; Jason K O'Donnell; Kenneth A Taylor; Scott M Stagg; Michael S Chapman
Journal:  Virology       Date:  2012-06-09       Impact factor: 3.616

4.  Chemical Modulation of Endocytic Sorting Augments Adeno-associated Viral Transduction.

Authors:  Garrett E Berry; Aravind Asokan
Journal:  J Biol Chem       Date:  2015-11-02       Impact factor: 5.157

5.  Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins.

Authors:  S Weger; A Wistuba; D Grimm; J A Kleinschmidt
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Structurally mapping the diverse phenotype of adeno-associated virus serotype 4.

Authors:  Lakshmanan Govindasamy; Eric Padron; Robert McKenna; Nicholas Muzyczka; Nikola Kaludov; John A Chiorini; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

7.  Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging.

Authors:  Svenja Bleker; Michael Pawlita; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant.

Authors:  C Hölscher; J A Kleinschmidt; A Bürkle
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element.

Authors:  Achille François; Mickaël Guilbaud; Rafi Awedikian; Gilliane Chadeuf; Philippe Moullier; Anna Salvetti
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.